Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is receiving European Commission and French government funds to develop vaccines that prote… https://t.co/Ijt0cLCBd0
    about 8 hours ago
  • New post on Science and Enterprise: EC, France Fund Universal Covid-19, Flu Vaccines https://t.co/qT6cmb5P1S #Science #Business
    about 8 hours ago
  • Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a dis… https://t.co/S4C9V2nW0p
    about 13 hours ago
  • New post on Science and Enterprise: Univ. Lab Discovers, Licenses Citrus Disease Treatment https://t.co/Hz2YkVgnac #Science #Business
    about 13 hours ago
  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 1 day ago

Please share Science & Enterprise

Infographic – What is Crispr?

Crispr explainer

(CB Insights)

9 Feb. 2019. One hot topic we’ve covered almost from the beginning at Science & Enterprise is Crispr — clustered, regularly interspaced short palindromic repeats — a genome editing technique derived from bacterial defense systems. Our first story about the technique dates back to August 2013, but we were also among the early chroniclers of financing for start-up companies commercializing Crispr like Editas Medicine and Crispr Therapeutics, now in full swing developing treatments and licensing their technologies.

Even as Crispr has gained commercial traction and public attention, there’s still a need for a good illustrated introduction to the technique, which or friends at CB Insights published on Thursday, our infographic for this weekend. The chart is part of a larger report on the state of Crispr technology and its applications. Listed below are links to some of our recent stories on Crispr.

More from Science & Enterprise:

*     *     *

Please share Science & Enterprise ...

1 comment to Infographic – What is Crispr?